Hong Kong Drug Licence Applications and Acquisitions · RGYS|Global Licensing and Compliance Service Provider
Hong Kong pharmaceutical compliance · applications / acquisitions / ongoing maintenance Independent Third-Party Service Provider
HONG KONG DRUG LICENSING

What are the main requirements for applying for a Hong Kong pharmaceutical import/export licence?

A complete explanation of the regulatory basis, Drew Tang’s recommendations and risk alerts. The original material dates from 2025; read it alongside the latest official requirements.

Original guide, 2025 edition: These FAQs are provided for topic-based reference and have not all been individually checked against current rules. Please confirm fees, personnel, renewal, changes and product requirements against the professional in-depth guide for the relevant licence type and the official requirements in force at the time.

Drug Office, Department of Health Chinese Medicines Board

Q481 · Category J: Cross-border pharmaceuticals and industry practice (Q451-Q500)
Under section 20 of the Pharmacy and Poisons Ordinance (Cap. 138), applicants for an import or export licence must hold a valid pharmaceutical licence and ensure that imported or exported medicines comply with Hong Kong’s quality and safety standards. Applicants must submit detailed information about the goods, the import or export destination and intended use, and must also have appropriate storage and transport conditions. The Drug Office, Department of Health will rigorously review the application documents to ensure compliance with the requirements for the regulation of medicines. Rengangyongsheng (Hong Kong) Limited recommends preparing all supporting documents in advance to avoid approval delays due to incomplete information.

📘 Regulatory basis

Section 20 of the Pharmacy and Poisons Ordinance (Cap.138); relevant Department of Health Drug Office guidance

📗 Drew Tang's recommendations

Be sure to prepare detailed medicine information and evidence of compliance, and communicate with the Department of Health in advance to improve approval efficiency.

📕 Risk notice

Inconsistent information or failure to hold a valid licence may result in the application being refused and may even lead to fines or criminal liability.

Back to Category J: Cross-border Medicines and Industry Practice (Q451-Q500) Search more questions

YOUR NEXT STEP

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang

Business Manager Tang Shangyong (Drew Tang) will review your products, operating model, licence type and preparation requirements with you one-to-one. The precise service scope is confirmed in writing; pharmaceutical duties are carried out by legally qualified personnel, and approvals are determined by the competent authorities.

Book a Project Assessment ↗